Group 1: Business Combination Announcement - Relativity Acquisition Corp. has received shareholder approval for its business combination with Instinct Bio Technical Company Inc., a leader in the stem cell and regenerative medicine sector [1] - The closing of the business combination is anticipated in the coming weeks, pending the satisfaction or waiver of all closing conditions [2] Group 2: Company Overview - Instinct Brothers operates as an integrated regenerative medicine and stem cell technology company, focusing on research, manufacturing, and commercialization of stem cell-derived products [3] - The company employs a vertically integrated model that combines scientific innovation, advanced manufacturing, and branding expertise to ensure high-quality products throughout the product lifecycle [3] Group 3: Relativity Acquisition Corp. Overview - Relativity Acquisition Corp. is a blank check company aimed at merging with businesses that have disruptive potential in health, wellness, and technology sectors [4]

Company Overview - Telix is an increasingly recognized company in the radiopharmaceutical space, focusing solely on oncology and radiopharmaceuticals with a precision medicine-oriented approach [2][3] - The company is vertically integrated, which allows it to control various aspects of its operations in the radiopharma sector [2] Product Development Strategy - Telix develops both imaging agents and therapeutic agents for each target, leveraging the valuable signals obtained from radiopharmaceuticals to understand efficacy and improve delivery [3][4] - This dual approach of combining imaging and therapeutic capabilities has proven beneficial for the company's commercial trajectory [4]